immuno-oncology

Illustration connected puzzle pieces with the acronym MA
Biotech

Ipsen inks €1B buyout of French biotech ImCheck

Ipsen is acquiring next-gen immuno-oncology biotech ImCheck for its investigational cancer combo therapy in a deal worth up $1.16 billion.
Gabrielle Masson Oct 22, 2025 10:33am
Nobel Prize medal with background of 100 bills

How Nobel-winning cells could become a 'universal drug'

Oct 21, 2025 2:00pm
Gut stomach

Gilead, Arcus keep TIGIT dream alive with 27-month OS data

Oct 13, 2025 7:05am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm
Bicycle bike ride travel

Bicycle lays off staff as Genentech rides away from R&D pact

Aug 8, 2025 8:50am
HKEX

Leads Biolabs hits Hong Kong stock exchange in $189M IPO

Jul 25, 2025 10:59am